Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines

M Chabaud, F Fossiez, JL Taupin… - The Journal of …, 1998 - journals.aai.org
IL-17 is a cytokine produced by CD4 T cells that activates the production of inflammatory
mediators by synoviocytes. To study the contribution of soluble factors in the interaction …

Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus

…, V Pitard, JF Viallard, JL Taupin… - … : Official Journal of …, 2005 - Wiley Online Library
Objective Cytotoxic T lymphocyte–mediated killing using granzyme B has recently been
proposed to be a preferential and selective source of autoantigens in systemic autoimmune …

Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss

…, E Morelon, JL Taupin… - Journal of the …, 2015 - journals.lww.com
Antibody-mediated rejection (AMR) is a major cause of kidney graft loss, yet assessment of
individual risk at diagnosis is impeded by the lack of a reliable prognosis assay. Here, we …

Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma

…, C Juhlin, M Matsuda, H Mellstedt, JL Taupin… - Cancer research, 1993 - AACR
An impaired immune response is frequently observed in cancer patients and tumor-bearing
mice. T-cells from mice with an experimental colon carcinoma were recently shown to …

[HTML][HTML] Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantion society working …

…, D Seron, AR Tambur, K Tanabe, JL Taupin… - …, 2020 - journals.lww.com
This meeting was organized by The Transplantation Society with the assistance of an
unconditional education grant from CSL Behring. CSL Behring had no involvement in the …

[PDF][PDF] Null leukemia inhibitory factor receptor (LIFR) mutations in Stüve-Wiedemann/Schwartz-Jampel type 2 syndrome

…, S Unger, S Nicole, B Fontaine, JL Taupin… - The American Journal of …, 2004 - cell.com
Stüve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized
by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened …

Non-complement–binding de novo donor-specific anti-HLA antibodies and kidney allograft survival

…, P Nickerson, P Merville, JL Taupin… - Journal of the …, 2016 - journals.lww.com
C1q-binding ability may indicate the clinical relevance of de novo donor-specific anti-HLA
antibodies (DSA). This study investigated the incidence and risk factors for the appearance of …

Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients

…, D Pievani, O Aubert, JPD Van Huyen, JL Taupin… - Kidney International, 2019 - Elsevier
Anti-angiotensin II type 1 receptor (AT1R) antibodies have been associated with allograft
rejection. We hypothesized that circulating AT1R antibodies might identify kidney transplant …

Major expansion of γδ T lymphocytes following cytomegalovirus infection in kidney allograft recipients

…, F Bergé, G Bone-Mane, JL Taupin… - The Journal of …, 1999 - academic.oup.com
In normal persons, circulating γδ T cells comprise a minor cell subset (0.5%–6% of total
lymphocytes). γδ T cells were studied in the context of therapeutic immunosuppression in …

Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants

…, H Païdassi, R Guillemain, JL Taupin… - Nature …, 2019 - nature.com
Current doctrine is that microvascular inflammation (MVI) triggered by a transplant -recipient
antibody response against alloantigens (antibody-mediated rejection) is the main cause of …